Clinical trial
A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the…
NCT00209443 · GE Healthcare, Industry · Completed
Key facts
| NCT number | NCT00209443 |
|---|---|
| Title | A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide |
| Official title | A Multicentre, Phase 3, Open-Label Study to Assess the Efficacy and Safety of 0.1 mmol/kg Omniscan (Gadodiamide Injection) for Magnetic Resonance Angiography (MRA) of the Aorto-iliac Arteries |
| Lead sponsor | GE Healthcare, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Aorto-iliac Stenosis, Arterial Occlusive Diseases |
| Intervention type | Drug |
| Interventions | Gadodiamide Injection |
| Enrollment | 407 |
| Start date | Sep 1, 2004 |
| Primary completion | Feb 28, 2006 |
| Completion | Feb 28, 2006 |
| First posted | Sep 21, 2005 |
| Last update posted | Apr 25, 2019 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: